Skip to main content
. 2025 Aug 29;7(8):001022.v3. doi: 10.1099/acmi.0.001022.v3

Table 2. Clinical categorization of hMPV-positive patients in the present study sample.

Clinical categorization Total no. (%) hMPV mono-infection (n=21) hMPV co-infection (n=5)
Upper respiratory tract infection 14 (53.84) 12 (57.14) 2 (40)
LRTI Bronchiolitis 2 (7.69) 1 (4.76) 1 (20)
Bronchopneumonia 8 (30.77) 6 (23.07) 2 (40)
Severe infection with mortality* 2 (7.69) 2 (9.52) 0

*Both patients were adults and severely immunocompromised following chemotherapy.